Matt Ridley is the author of provocative books on evolution, genetics and society. His books have sold over a million copies, been translated into thirty languages, and have won several awards.
Please note that this blog does not accept comments. If you're reading this blog and want to respond then please use the contact form on the site, or comment on his Facebook page. You can also follow him on Twitter @mattwridley.
His new book How Innovation Works is now available in the UK as well as in the US and Canada.
My Times column on Nicole Kidman's performance as Rosalind Franklin in Photograph 51:
It’s not been a good fortnight for actresses and scientific accuracy. Last week Emma Thompson told the BBC that the world will warm by 4C by 2030 — about 3.5C too high, according to the experts. This week Nicole Kidman, whose performance as the DNA scientist Rosalind Franklin in Anna Ziegler’s play Photograph 51 begins its run on Monday, said she hopes to “put the spotlight” on the “inequality” of Franklin not getting the Nobel prize for the discovery of the structure of DNA. “She was not nominated. That’s not right.”
This is a pernicious myth, no less wrong for being well meant. Franklin was not nominated for the Nobel prize in 1962 because she was dead. The rules of the prizes are clear: they are only granted to the living. Had she lived it is highly likely she would have been nominated. Given that the discovery of the double helix in February 1953 was one of the greatest moments in science — up there with gravity, relativity and natural selection — it is crucial we do not let actresses rewrite the history.
My Times column is on the risks of genetic research and therapy:
Fifteen years after the first sequencing of the human genome, the genetic engineering of human beings is getting closer. Will that mean designer babies and the rich winning life’s lotteries from the start? And will we ever stop this slither down the slippery slope to playing God? My answers are: no, and I hope not. Despite dire predictions, almost nothing but good has come from genetic technology so far, and we’ve proved that we don’t slip down such slopes: we tread carefully.
The current excitement is over gene editing. A precise way of doing this, called CRISPR-cas9, is all the rage among the white-coated pipette-users. Last week, Britain’s five leading medical research bodies (one of which, I should declare, counts me as a fellow, the Academy of Medical Sciences) issued a joint statement supporting the careful use of the new technique on human cells for research and possibly therapy. They even recognised that there might one day be a justifiable demand to use the new technique on embryos in such a way that the changes would be inherited.
My Times column on African demography and the migration crisis:
Even the most compassionate of European liberals must wonder at times whether this year’s migration crisis is just the beginning of a 21st- century surge of poor people that will overwhelm the rich countries of our continent. With African populations growing fastest, are we glimpsing a future in which the scenes we saw on the Macedonian border, or on Kos or in the seas around Sicily last week will seem tame?
I don’t think so. The current migration crisis is being driven by war and oppression, not demography. Almost two thirds of the migrants reaching Europe by boat this year are from three small countries: Syria, Afghanistan and Eritrea. These are not even densely populated countries: their combined populations come to less than England’s, let alone Britain’s, and none of them is in the top 20 for population growth rates.
Receive all my latest posts straight to your inbox. simply subscribe below:
[*] denotes a required field